Modera Wealth Management LLC Has $16.25 Million Position in Stryker Co. (NYSE:SYK)

Modera Wealth Management LLC raised its stake in shares of Stryker Co. (NYSE:SYK) by 5.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 45,132 shares of the medical technology company’s stock after purchasing an additional 2,387 shares during the period. Modera Wealth Management LLC’s holdings in Stryker were worth $16,250,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of SYK. SRS Capital Advisors Inc. lifted its position in Stryker by 16.4% during the 4th quarter. SRS Capital Advisors Inc. now owns 327 shares of the medical technology company’s stock worth $118,000 after acquiring an additional 46 shares during the last quarter. Norden Group LLC increased its stake in shares of Stryker by 22.4% in the fourth quarter. Norden Group LLC now owns 1,056 shares of the medical technology company’s stock worth $380,000 after purchasing an additional 193 shares during the period. Kohmann Bosshard Financial Services LLC acquired a new position in shares of Stryker during the 4th quarter worth about $25,000. Smartleaf Asset Management LLC boosted its stake in Stryker by 44.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 6,341 shares of the medical technology company’s stock valued at $2,297,000 after purchasing an additional 1,944 shares during the period. Finally, Purkiss Capital Advisors LLC acquired a new stake in Stryker in the 4th quarter valued at approximately $375,000. Institutional investors own 77.09% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the company. Stifel Nicolaus increased their price objective on Stryker from $400.00 to $440.00 and gave the company a “buy” rating in a research report on Wednesday, January 29th. JPMorgan Chase & Co. upped their target price on Stryker from $420.00 to $445.00 and gave the company an “overweight” rating in a research note on Wednesday, January 29th. Citigroup reissued a “buy” rating and issued a $450.00 price target on shares of Stryker in a report on Wednesday. StockNews.com downgraded shares of Stryker from a “buy” rating to a “hold” rating in a report on Tuesday, February 25th. Finally, Argus set a $450.00 target price on shares of Stryker in a research note on Monday, February 3rd. Five research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $422.15.

Insider Buying and Selling at Stryker

In related news, Director Allan C. Golston sold 2,458 shares of Stryker stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $383.07, for a total value of $941,586.06. Following the sale, the director now owns 14,895 shares of the company’s stock, valued at approximately $5,705,827.65. The trade was a 14.16 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Ronda E. Stryker sold 201,392 shares of the firm’s stock in a transaction that occurred on Friday, January 31st. The shares were sold at an average price of $392.24, for a total value of $78,993,998.08. Following the completion of the transaction, the director now owns 3,642,075 shares of the company’s stock, valued at approximately $1,428,567,498. This represents a 5.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 5.90% of the company’s stock.

Stryker Stock Down 0.6 %

Shares of NYSE:SYK opened at $386.55 on Friday. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32. The stock has a market cap of $147.50 billion, a price-to-earnings ratio of 49.81, a P/E/G ratio of 2.93 and a beta of 0.96. The company has a 50 day moving average of $380.50 and a 200-day moving average of $371.22. Stryker Co. has a one year low of $314.93 and a one year high of $406.19.

Stryker (NYSE:SYK) last released its earnings results on Tuesday, January 28th. The medical technology company reported $4.01 EPS for the quarter, topping analysts’ consensus estimates of $3.87 by $0.14. Stryker had a net margin of 13.25% and a return on equity of 23.58%. During the same quarter last year, the firm posted $3.46 earnings per share. On average, sell-side analysts forecast that Stryker Co. will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 30th. Stockholders of record on Monday, March 31st will be given a dividend of $0.84 per share. The ex-dividend date is Monday, March 31st. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.87%. Stryker’s dividend payout ratio is 43.30%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.